Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001325812-11-000021)

Filing Details

Accession Number:: 0001325812-11-000021
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-10-13 17:09:15
Reporting Period:: 2011-10-11

Filing Date:: 2011-10-13
Accepted Time:: 2011-10-13 17:09:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178670	Alnylam Pharmaceuticals Inc.	ALNY	Pharmaceutical Preparations (2834)	770602661

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1291963	E Barry Greene	C/O Alnylam Pharmaceuticals, Inc 300 Third Street Cambridge MA 02142	President And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-10-11	742	$6.73	742	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,849	Indirect	by Managed Account

Footnotes

The purchases reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2011.
Purchase prices ranged from $6.73 to $6.75.
The reporting person owns 1,849 shares of ALNY common stock under the ALNY 401(k) Plan as a result of the ALNY 401(k) matching contribution program.